Stay informed about our latest innovations, products and scientific news. Learn more about Eurofins CALIXAR through our press releases and biotech events and find out why we are at the forefront of protein technology.

April 4, 2024

New Pure & Active CD20 protein for Drug Discovery!

October 20, 2023

Eurofins CALIXAR will attend the 3rd IRN I-GPCRNET Annual Meeting from October 25th to 27th, 2023

October 13, 2023

New molecules for the stabilization of membrane proteins, a new research article

April 28, 2023

CALIXAR will attend the Protein & Antibody Engineering Summit (PEGS US) on May 15 – 19 2023 at Boston

Press releases
April 6, 2023

Eurofins Discovery Acquires CALIXAR, Expanding Integrated Drug Discovery Capabilities and Expertise

March 24, 2023

Résultats de l’année 2022 - Results of the year 2022

March 10, 2023

CALIXAR obtient le renouvellement de son agrément « Crédit d’Impôt Recherche » (CIR) pour 5 ans

March 3, 2023

CALIXAR will participate to the 7th AMR Conference at Basel (Switzerland) on March 16 - 17, 2023

February 24, 2023

Calixar: target proteins for drug development

February 17, 2023

New distributor agreement between CALIXAR and

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.